["{\n\"step_by_step_thinking\": \"After reviewing the relevant documents, I can see that the question is asking about preoperative administration of blood products to patients with classic hemophilia. Document 1 (Surgery in hemophilic patients) mentions factor-replacement therapy for surgery in hemophilic patients. Document 3 (Surgery of hemophiliacs--20 years' experience) emphasizes the importance of prolonged substitution therapy postoperatively to avoid late hematoma, particularly in patients with severe hemophilia undergoing major surgery. Based on these documents, it is likely that factor replacement therapy would be the best option for preoperative administration.\",\n\"answer_choice\": \"B\"\n}"]